Control of acute myeloid leukemia morbidity in northwest Iran.
Artículo
en Inglés
| IMSEAR
| ID: sea-37357
ABSTRACT
BACKGROUND:
To investigate protocols of remission induction therapy for prevention of morbidity of acute myeloid leukemia. MATERIALS ANDMETHODS:
The responses of 150 patients to "2+5" and "3+7" protocols during 1996-2003 were assessed and analyzed with the Chi-Square method.RESULTS:
Complete remission was observed in 30% of cases treated with 2 days of daunorubicin and 5 days of cytarabine (2+5 regimen). Remission was increased to 52.5% when patients were treated with 3+7 regimens with the same drugs. Partial remission resulted in 25 and 10 percent of cases, respectively.CONCLUSION:
As in previous studies the 3+7 regimen was demonstrated to be more effective than the 2+5 regimen in our hospital (p=0.0009).
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Inducción de Remisión
/
Humanos
/
Esquema de Medicación
/
Leucemia Mieloide Aguda
/
Daunorrubicina
/
Estudios Retrospectivos
/
Adolescente
/
Adulto
/
Citarabina
/
Irán
Tipo de estudio:
Guía de Práctica Clínica
/
Estudio observacional
País/Región como asunto:
Asia
Idioma:
Inglés
Año:
2005
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS